Notice of Special Interest - R35 (Undergraduate Summer Funding)
Project Number3R35GM142527-01S1
Former Number1R35GM142527-01
Contact PI/Project LeaderLEE, AMY SI-YING
Awardee OrganizationDANA-FARBER CANCER INST
Description
Abstract Text
Project Summary
Exquisite spatial and temporal control of the proteins that are expressed in a cell is essential for correct
differentiation and cell growth decisions. Despite being a central step in gene expression, how mRNA translation
is regulated remains poorly understood. There is a gap in our understanding of the molecular basis of specialized
translation of specific transcripts, and of the overall functional significance of this regulation on cellular responses
to signaling cues. Here we propose to investigate the contribution of mRNA translation regulation to the dynamic
gene expression programs that underlie cell physiology. The system we will focus on is the 13-subunit eIF3
translation initiation factor complex, which acts as a scaffold during general translation to organize interactions
between the small ribosomal proteins and other initiation factors. We recently discovered that eIF3 can also
control the translation of select cellular transcripts through novel RNA-binding and cap-binding activities. These
findings demonstrate that canonical translation initiation factors moonlight in roles outside of general translation
to drive expression of distinct gene programs. Despite these intriguing findings, and eIF3 being the largest
component of the translation machinery besides the ribosome, ascribing functions to the majority of subunits has
been challenging. Standard genetic techniques cannot be applied to eIF3; eIF3 subunits are essential for
viability, and the assembly of the multi-subunit eIF3 complex is hindered by alterations to subunit levels. These
methods also cannot segregate activities in general versus specialized translation. We will develop an innovative
set of high-throughput methodologies to address these difficulties and comprehensively discover how eIF3
controls the dynamic gene programs during cell differentiation and cellular response to extrinsic signals. By
combining these broad approaches with detailed biochemical and cell-based approaches, we will provide
molecular understanding of the translation regulation networks that coordinate the precise control required for
correct cellular function and signaling. This research will create new insights into fundamental principles of gene
regulation. As eIF3 and other initiation factors are genetically associated with cancer, aging, congenital disorders,
this work will also guide unconventional approaches to target translation regulation in disease.
Public Health Relevance Statement
Project Narrative
Gene expression is highly regulated by cells to allow for correct function and response to extrinsic signals.
Despite protein synthesis being a fundamental process in gene expression, our understanding of the
mechanisms of specialized mRNA translation remains limited. The proposed research will determine how
translation initiation factors regulate cellular phenotypes, and has implications on rational design of therapeutics
targeting gene dysregulation in human disease.
No Sub Projects information available for 3R35GM142527-01S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R35GM142527-01S1
Patents
No Patents information available for 3R35GM142527-01S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R35GM142527-01S1
Clinical Studies
No Clinical Studies information available for 3R35GM142527-01S1
News and More
Related News Releases
No news release information available for 3R35GM142527-01S1
History
No Historical information available for 3R35GM142527-01S1
Similar Projects
No Similar Projects information available for 3R35GM142527-01S1